Dr. Nevine El-leithy Joins NeuroLight as its Chief Scientific Officer
NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting brain states™, hires Dr. Nevine El-leithy as the Chief Scientific Officer (CSO). Former Research Director and Professor of Deep Brain Neurotech at the University of Maryland, Dr. El-leithy will lead NeuroLight’s R&D focused on developing a non-pharmaceutical treatment for insomnia and other sleep disorders […]
NeuroLight Awarded Competitive Grant from the U.S. National Science Foundation
NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting mental states™, awarded grant from the U.S. National Science Foundation (NSF)
Neuroenhancement Lab, Inc. Announces Rebrand as NeuroLight
Neuroenhancement Lab, Inc., a neuromodulation company first to develop technology for transplanting mental states™ from one person to another, rebrands itself as NeuroLight.
Parisa Khosropour Joins Advisory Board of Neuroenhancement Lab, Inc.
Suffern, N.Y., February 25, 2018—Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour joined its Advisory Board. As a pioneer in neuromodulation, Neuroenhancement Lab is the first company to develop technology for transplanting mental state™ from one person to another. “We are very pleased to welcome Parisa to our […]
